Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
TWST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$27.41 - $60.90
Previous CloseN/A
Volume152.02K
Average Volume (3M)1.16M
Market Cap
$2.56B
Enterprise Value$2.56B
Total Cash (Recent Filing)$266.27M
Total Debt (Recent Filing)$35.98M
Price to Earnings (P/E)―
Beta3.57
Next Earnings
May 01, 2025EPS Estimate
-0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.38
Shares Outstanding59,651,142
10 Day Avg. Volume1,121,909
30 Day Avg. Volume1,160,134
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.75
Price to Cash Flow (P/CF)-29.90
P/FCF Ratio0.00
Enterprise Value/Market Cap1.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit19.21
Enterprise Value/Ebitda-15.52
Forecast
1Y Price Target
$53.33Price Target Upside24.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
---
Twist Bioscience News
PremiumCompany Announcements
Twist Bioscience Stockholders Approve Key Amendments
PremiumCompany Announcements
Twist Bioscience Reports Record Quarterly Revenue
PremiumCompany Announcements
Twist Bioscience’s Earnings Call Highlights Strong Growth---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTWST delivered a slight beat, with FY1Q25 revenue exceeding expectations and gross margin coming in particularly strong.
Market PositionTwist Bioscience is well-positioned to outperform, as management commentary and recent performance support this view.
Revenue GrowthThe company's FY25 revenue guidance was raised, with significant contributions from the SynBio and BioPharma segments.
Bears Say
Market UncertaintyThere are questions around TWST's continued ability to take market share at current levels, given an uncertain sector backdrop.
Regulatory EnvironmentThe guide implies significant deceleration, which is viewed as prudent in a changing regulatory environment.
Sector OutlookThe outlook for the sector is likely to weigh on the shares in the near-medium term until R&D growth across pharma is more clear.
---
Ownership Overview
3.17% Insiders
28.32% Mutual Funds
0.08% Other Institutional Investors
41.29% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $27.41 and its highest was $60.90 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Twist Bioscience Corp’s market cap is $2.56B.
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is May 01, 2025 which is in 38 days.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on Feb 03, 2025. The company reported -$0.53 earnings per share for the quarter, beating the consensus estimate of -$0.625 by $0.095.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Undervalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -0.55.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 59,651,142 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of -$0.53 in its last earnings report, beating expectations of -$0.625. Following the earnings report the stock price went up 0.726%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Currently, no hedge funds are holding shares in TWST
---
Twist Bioscience Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$53.33 (24.34% Upside)
$53.33 (24.34% Upside)
Blogger Sentiment
Bullish
TWST Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 110.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $156.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 4.3%
Last 30 Days ▼ 4.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
19.03%
12-Months-Change
Fundamentals
Return on Equity
-37.73%
Trailing 12-Months
Asset Growth
-16.95%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.
---
TWST Company Deck
---
TWST Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance in revenue growth and gross margin improvement, driven by the SynBio and NGS segments. While there are challenges in the Biopharma segment and limited exposure to China, the company's strategic investments and innovative platform position it for future growth.Read More>---
TWST Stock 12 Month Forecast
Average Price Target
$53.33
▲(24.34% Upside)
Technical Analysis
Illumina
―
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Ginkgo Bioworks Holdings
―
Best Analysts Covering TWST
1 Year
1 Year Success Rate
5/11 ratings generated profit
1 Year Average Return
-24.20%
reiterated a sell rating 2 months ago
Copying Rachel Vatnsdal's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of -24.20% per trade.
---